Abstract:Background: The tripartite motif (TRIM) family are important members of the Gene-finger-containing E3 ubiquitin-conjugating enzyme and are involved in the progression of hepatocellular carcinoma (HCC). Previous studies have largely focused on gene expression and molecular pathways, while the underlying role of the TRIM family in the tumor immune microenvironment (TIME) remains poorly understood.Methods: We systematically explored the correlations of prominent TRIM genes with immune checkpoints and immune infiltrates in 231 HCC samples [International Cancer Genome Consortium (ICGC) cohort (n=231); The Cancer Genome Atlas (TCGA) cohort (n=370)]. A prognostic risk model was constructed using the least absolute shrinkage and selection operator (LASSO) algorithm and multivariate Cox regression analysis in the ICGC cohort. Kaplan-Meier curves based on the overall survival (OS) were used to assess differences in survival between clusters. We utilized gene set variation analysis (GSVA) to characterize the differences in biological functions. Based on univariate and multivariate Cox progression analysis, we developed a risk score signature and verified its reliability and validity. The Tumor Immune Single-cell Hub (TISCH) single-cell database was employed to evaluate the correlation of TRIM genes with the tumor microenvironment.Results: Cluster 1 was preferentially associated with a favorable prognosis (P<0.001). The amino acid, fatty acid, and drug metabolism pathways were significantly enriched in cluster 2. A prognosis risk score project was established and evaluated based on the 9 independent prognostic genes (all P<0.05). The immune score and stromal scores of patients with low-risk scores were greater than those of patients with high-risk scores (all P<0.001). However, patients with a high-risk score exhibited lower responses to immune check-point inhibitors (ICIs), sorafenib, and transarterial chemoembolization (TACE) treatment (all P<0.05). Consistently, TRIM genes showed the same influence in the external TCGA cohort. TRIM gene-based signatures were implicated in TIME and their copy-number alterations dynamically impacted the abundance of tumor-infiltrating immune cells.Conclusions: Our findings revealed that MID1, TRIM5, TRIM22, TRIM28, TRIM 31, TRIM37, TRIM38, TRIM47, and TRIM74 could serve as efficient prognostic biomarkers and therapeutic targets in HCC. The identified TRIM gene-based signatures could serve as important TIME mediators in HCC, potentially increasing immune treatment efficacy.

TRIM56: a promising prognostic immune biomarker for glioma revealed by pan-cancer and single-cell analysis

Comprehensive profiling of the TRIpartite motif family to identify pivot genes in hepatocellular carcinoma

TRIM6: An Upregulated Biomarker with Prognostic Significance and Immune Correlations in Gliomas

TRIM56 Promotes Malignant Progression of Glioblastoma by Stabilizing Ciap1 Protein.

[Increased TRIM5 is Associated with a Poor Prognosis and Immune Infiltration in Glioma Patients].

High TRIM59 Expression Predicts Adverse Outcomes and is Correlated with Immune Infiltrates in Lung Adenocarcinoma

Identification of a Tripartite Motif Family Gene Signature for Predicting the Prognosis of Patients with Glioma.

TRIM21 Overexpression Promotes Tumor Progression by Regulating Cell Proliferation, Cell Migration and Cell Senescence in Human Glioma.

Integrated Bioinformatics Analysis Reveals Correlations of High TRIM59 Expression with Worse Prognosis and Immune Infiltrates in Lung Adenocarcinoma

TRIM28 as an independent prognostic marker plays critical roles in glioma progression

TRIM31 Promotes Proliferation, Invasion and Migration of Glioma Cells Through Akt Signaling Pathway.

Upregulated Tripartite Motif 47 Could Facilitate Glioma Cell Proliferation and Metastasis as a Tumorigenesis Promoter

TRIM59: A potential diagnostic and prognostic biomarker in human tumors

TRIM29 is Differentially Expressed in Colorectal Cancers of Different Primary Locations and Affects Survival by Regulating Tumor Immunity Based on Retrospective Study and Bioinformatics Analysis

Pan-cancer Illumination of TRIM Gene Family Reveals Immunology Regulation and Potential Therapeutic Implications

TRIM5 as a promising diagnostic biomarker of hepatocellular carcinoma: integrated analysis and experimental validation

TRIM31 Promotes Glioma Proliferation and Invasion Through Activating NF-κB Pathway.

A Systematic Pan-Cancer Analysis Identifies TRIM28 As an Immunological and Prognostic Predictor and Involved in Immunotherapy Resistance.

Bioinformatics analysis of immune infiltrates and tripartite motif (TRIM) family genes in hepatocellular carcinoma

Integrated Bioinformatics and Experimental Analysis Identified TRIM28 a Potential Prognostic Biomarker and Correlated with Immune Infiltrates in Liver Hepatocellular Carcinoma

TRIM27 is an adverse prognostic biomarker and associated with immune and molecular profiles in right-sided colon cancer